MTOR and neoplasm: TKIs target enzymes that are responsible for the activation of several intracellular molecular pathways often involved in tumor cell proliferation, such as phosphatidylinositol 3-kinase (PI3K), thymoma viral proto-oncogene (AKT), and mammalian target of rapamycin (mTOR) [19–21].